| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ACRX | ACELRX PHARMACEUTICALS INC | Hamel Lawrence G | Chief Development Officer | Feb 11, 2020 | Option Exercise | $1.71 | 5,613 | 9,598 | 127,769 | Feb 13, 2020, 04:14 PM | |
| ACRX | ACELRX PHARMACEUTICALS INC | Hamel Lawrence G | Chief Development Officer | Feb 28, 2019 | Buy | $2.81 | 3,682 | 10,346 | 78,053 | Mar 04, 2019, 04:24 PM | |
| ACRX | ACELRX PHARMACEUTICALS INC | Hamel Lawrence G | Chief Development Officer | Nov 02, 2018 | Option Exercise | $3.61 | 10,000 | 36,125 | 34,795 | Nov 05, 2018, 05:29 PM | |
| ACRX | ACELRX PHARMACEUTICALS INC | Hamel Lawrence G | Chief Development Officer | Oct 15, 2018 | Sale | $5.00 | 5,216 | 26,080 | 29,795 | Oct 16, 2018, 04:30 PM | |
| ACRX | ACELRX PHARMACEUTICALS INC | Hamel Lawrence G | Chief Development Officer | Sep 24, 2018 | Sale | $4.50 | 6,953 | 31,289 | 35,011 | Sep 26, 2018, 05:54 PM | |
| ACRX | ACELRX PHARMACEUTICALS INC | Hamel Lawrence G | Chief Development Officer | Aug 31, 2018 | Option Exercise | $1.49 | 6,876 | 10,245 | 24,371 | Sep 05, 2018, 06:06 AM | |
| ACRX | ACELRX PHARMACEUTICALS INC | Hamel Lawrence G | Chief Development Officer | Oct 02, 2017 | Sale | $5.29 | 10,161 | 53,752 | 41,964 | Oct 03, 2017, 12:00 AM | |
| ACRX | ACELRX PHARMACEUTICALS INC | Hamel Lawrence G | Chief Development Officer | Apr 10, 2017 | Option Exercise | $1.20 | 9,122 | 10,946 | 73,475 | Apr 11, 2017, 05:29 PM | |
| ACRX | ACELRX PHARMACEUTICALS INC | Hamel Lawrence G | Chief Development Officer | Jul 17, 2014 | Option Exercise | $2.89 | 4,962 | 14,324 | 65,353 | Jul 21, 2014, 04:07 PM | |
| ACRX | ACELRX PHARMACEUTICALS INC | Hamel Lawrence G | Chief Development Officer | Jun 17, 2014 | Option Exercise | $2.94 | 5,354 | 15,735 | 62,391 | Jun 19, 2014, 04:37 PM | |
| ACRX | ACELRX PHARMACEUTICALS INC | Hamel Lawrence G | Chief Development Officer | May 19, 2014 | Option Exercise | $2.84 | 4,658 | 13,230 | 59,037 | May 20, 2014, 04:05 PM | |
| ACRX | ACELRX PHARMACEUTICALS INC | Hamel Lawrence G | Chief Development Officer | Apr 17, 2014 | Option Exercise | $2.94 | 5,329 | 15,645 | 56,379 | Apr 18, 2014, 06:58 PM | |
| ACRX | ACELRX PHARMACEUTICALS INC | Hamel Lawrence G | Chief Development Officer | Mar 17, 2014 | Option Exercise | $3.03 | 6,216 | 18,839 | 53,050 | Mar 19, 2014, 04:11 PM | |
| ACRX | ACELRX PHARMACEUTICALS INC | Hamel Lawrence G | Chief Development Officer | Mar 02, 2014 | Option Exercise | $11.43 | 1,569 | 17,934 | 47,834 | Mar 11, 2014, 03:24 PM | |
| ACRX | ACELRX PHARMACEUTICALS INC | Hamel Lawrence G | Chief Development Officer | Feb 18, 2014 | Option Exercise | $3.00 | 5,878 | 17,624 | 47,880 | Feb 20, 2014, 03:32 PM | |
| ACRX | ACELRX PHARMACEUTICALS INC | Hamel Lawrence G | Chief Development Officer | Jan 17, 2014 | Option Exercise | $3.04 | 6,283 | 19,080 | 44,002 | Feb 04, 2014, 07:49 PM | |
| ACRX | ACELRX PHARMACEUTICALS INC | Hamel Lawrence G | Chief Development Officer | Jan 17, 2014 | Option Exercise | $3.04 | 6,283 | 19,080 | 41,944 | Jan 22, 2014, 05:45 PM | |
| ACRX | ACELRX PHARMACEUTICALS INC | Hamel Lawrence G | Chief Development Officer | Dec 17, 2013 | Option Exercise | $2.90 | 5,058 | 14,670 | 39,719 | Dec 19, 2013, 03:36 PM | |
| ACRX | ACELRX PHARMACEUTICALS INC | Hamel Lawrence G | Chief Development Officer | Nov 18, 2013 | Option Exercise | $2.80 | 4,433 | 12,420 | 36,661 | Nov 20, 2013, 12:40 PM | |
| ACRX | ACELRX PHARMACEUTICALS INC | Hamel Lawrence G | Chief Development Officer | Oct 17, 2013 | Option Exercise | $2.82 | 4,520 | 12,764 | 34,228 | Oct 18, 2013, 04:37 PM | |
| ACRX | ACELRX PHARMACEUTICALS INC | Hamel Lawrence G | Chief Development Officer | Sep 17, 2013 | Option Exercise | $2.95 | 5,437 | 16,034 | 31,708 | Sep 19, 2013, 02:14 PM | |
| ACRX | ACELRX PHARMACEUTICALS INC | Hamel Lawrence G | Chief Development Officer | Mar 02, 2013 | Option Exercise | $4.96 | 1,549 | 7,683 | 26,578 | Mar 05, 2013, 09:27 PM | |
| ACRX | ACELRX PHARMACEUTICALS INC | Hamel Lawrence G | Chief Development Officer | Mar 02, 2012 | Option Exercise | $2.91 | 1,540 | 4,481 | 13,820 | Mar 09, 2012, 03:52 PM | |
| ACRX | ACELRX PHARMACEUTICALS INC | Hamel Lawrence G | Chief Development Officer | Mar 02, 2012 | Option Exercise | $2.91 | 1,717 | 4,996 | 13,643 | Mar 06, 2012, 04:28 PM | |
| ACRX | ACELRX PHARMACEUTICALS INC | Hamel Lawrence G | Chief Development Officer | Sep 02, 2011 | Option Exercise | $3.10 | 1,539 | 4,771 | 15,360 | Sep 08, 2011, 05:06 PM |
Menu